UFP Technologies (UFPT) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

UFP Technologies

NasdaqCM•Healthcare•Medical Devices

$275.41-4.00(-0.01%)Pre-market

Market Cap

$2.14B

P/E

29.6x

P/S

3.4x

P/B

4.6x

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

How this company scores

GoodMetricSide Score: 78/100

Strongest: Profitability (24/25); weakest: Cash & Earnings Quality (14/25).

Profitability24/25

Growth18/25

Balance Sheet & Red Flags22/25

Cash & Earnings Quality14/25

Strengths

Strong marginsHigh ROELow leverageInterest easily covered

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 29.6x5y range 17.8x – 44.8x

Currently near its 20-quarter median.

P/S · 3.4x5y range 2.0x – 5.3x

Currently near its 20-quarter median.

P/B · 4.6x5y range 2.5x – 7.4x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Margin Pressure

Watch

Operating margins declined 5.2% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $2.14B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $631.64M
Q. Revenue: $173.96M
TTM EBITDA: $111.21M
TTM Op. Income: $96.35M
Q. Op. Income: $28.10M
TTM Net Income: $72.30M
Q. Net Income: $20.85M
EPS: $2.69
Shares Out.: $7.74M

$631.64M in TTM revenue grew 7.3% YoY, reaching $173.96M last quarter. TTM EBITDA of $111.21M and TTM operating income of $96.35M show growth is flowing through to the bottom line. TTM net income of $72.30M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 29.3%
EBITDA Margin: 19.0%
Op. Margin: 16.2%
Net Margin: 12.0%

Op. margin of 16.2% is up 0.1% YoY — cost efficiency is improving. Net margin at 12.0% and gross margin of 29.3% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 29.6x
P/S Ratio: 3.4x
P/B Ratio: 4.6x

At 29.6x P/E, the stock trades within typical market levels. P/S of 3.4x and P/B of 4.6x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 6% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $681.91M
Cash: $9.04M
Long-Term Debt: $104.81M
Book Value: $462.43M
D/E Ratio: 0.2
Debt/EBITDA: 3.2

With $681.91M in assets and $104.81M in long-term debt, D/E is 0.2and book value is $462.43M — a conservative capital structure with a cushion to weather downturns. Across the last 8 quarters, debt/equity has fallen for 7 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $15.61M
TTM Free Cash Flow: $61.42M
FCF Margin: 9.7%
FCF / Net Income: 0.8

TTM FCF of $61.42M on $15.61M in operating cash flow. The FCF / Net Income ratio of 0.8x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has fallen for 3 consecutive quarters — a weakening trend.